Detailed price information for Roche Holding Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.
Roche (RHHBF) (RHHBY) shares fell after the Swiss drugmaker’s investigational breast cancer pill failed to meet the primary goal of a late-stage breast cancer trial. The persevERA Breast Cancer study ...
Recent Moves and What They Mean for Investors Roche Holding (SWX:ROG) has been on investors’ radar after recent share price ...
Olema Pharmaceuticals (OLMA) stock plummeted 41% after Roche's Phase 3 breast cancer trial failed its primary endpoint, though analysts see opportunity.
Roche Holding AG expands Nvidia AI GPUs for drug R&D, tops peers with 3,500+ Blackwell chips, see value vs Eli Lilly and ...
Roche's shares declined sharply after its breast cancer drug, giredestrant, failed a key trial. The drug didn't show meaningful progress when combined with Ibrance. Despite this, analysts see ...